Featured post

GE's management is likely to become an agent of Xi Jinping regime

GE has 7 subsidiaries in China: GE Healthcare (China) Co., Ltd, GE Healthcare (Shanghai) Co Ltd, GE Hydro China Co., Ltd, GE Medical Systems Trade and Development (Shanghai) Co., Ltd, etc., which are involved in the CCP's medical, aviation, energy and other industries.



The above financial figures of GE as of 31 December 2021 have been issued an unqualified audit report. The PCAOB website states that it is unable to check the audit papers of accountants located in mainland China and Hong Kong related to the mainland China branch of non-China companies, although the major auditor is not located in mainland China and Hong Kong. There is high risk of GE management corruption and misstatement of financial statements of China business.



There's Great Firewall in China that prevents corruption being exposed.

GE and the CCP’s virus economy are tied together.

GE Healthcare China's digital healthcare strategy is based on the Edison digital healthcare intelligence platform, combining hospital intelligent management (APM, RCC Radiology Command Center, Mural Intensive Care Command Center), cloud computing (cloud ECG, cloud imaging) and artificial intelligence (Full-process artificial intelligence magnetic resonance technology platform, coronary medical image processing AI analysis system, COVID19 AI analysis platform LK2.0).

GE Healthcare has a CT scanning system and X-ray imaging system factory in Beijing, where two out of every three CTs in the world are produced; it has a contrast agent production base in Shanghai, and 90% of the contrast agent produced is supplied to the global market.

GE Healthcare has a production base for magnetic resonance imaging systems in Tianjin. One out of every two magnetic resonance products GE sells globally comes from the Tianjin factory; it has a factory in Wuxi for clinical care equipment such as ultrasound, anesthesia, ECG, and patient monitoring.

Ultrasound products produced by the Wuxi factory account for 40% of GE's global ultrasound sales.

GE has heavy reliance on made in China. Chinese Communist Party released viruses to benefit medial and biological giants, making GE's management more likely standing with CCP.

It's necessary to make laws to require any company or its management that transact with economies or invest in economies, where PCAOB's inspection is rejected, to register with Department of Justice as a foreign agent.




The information regarding GE's operation in China extracted from its annual report as follows:
global economic trends, competition and geopolitical risks, including changes in the rates of investment or economic growth in key markets we serve, or an escalation of sanctions, tariffs or other trade tensions between the U.S. and China or other countries, and related impacts on our businesses' global supply chains and strategies;
products, services and activities are subject to a number of global regulators such as the U.S. Federal Aviation Administration (FAA), European Union Aviation Safety Agency (EASA), Civil Aviation Administration of China (CAAC) and other regulatory bodies.
RPO as of December 31, 2021 increased $1.7 billion (13%) from December 31, 2020 primarily due to new service contracts and renewals with large customers and from equipment on strong orders across all regions, notably in China and the U.S., as well as supply chain challenges in converting RPO to revenues.
Our operations and the execution of our business plans and strategies are subject to the effects of global economic trends, geopolitical risks and demand or supply shocks from events that could include war, a major terrorist attack, natural disasters or actual or threatened public health emergencies (such as COVID-19). They are also affected by local and regional economic environments and policies in the U.S. and other markets that we serve, including interest rates, monetary policy, inflation, economic growth, recession, commodity prices, currency volatility, currency controls or other limitations on the ability to expatriate cash, sovereign debt levels and actual or anticipated defaults on sovereign debt. For example, changes in local economic conditions or outlooks, such as lower rates of investment or economic growth in China, Europe or other key markets, affect the demand for or profitability of our products and services outside the U.S., and the impact on the Company could be significant given the extent of our activities outside the United States. Political changes and trends such as populism, protectionism, economic nationalism and sentiment toward multinational companies and resulting tariffs, export controls or other trade barriers, or changes to tax or other laws and policies, have been and may continue to be disruptive and costly to our businesses, and these can interfere with our global operating model, supply chain, production costs, customer relationships and competitive position. Further escalation of specific trade tensions, including intensified decoupling between the U.S. and China, or in global trade conflict more broadly could be harmful to global economic growth or to our business in or with China or other countries, and related decreases in confidence or investment activity in the global markets would adversely affect our business performance. We also do business in many emerging market jurisdictions where economic, political and legal risks are heightened.
We, our representatives, and the industries in which we operate are subject to continuing scrutiny by regulators, other governmental authorities and private sector entities or individuals in the U.S., the European Union, China and other jurisdictions, which have led or may, in certain circumstances, lead to enforcement actions, adverse changes to our business practices, fines and penalties, required remedial actions such as contaminated site clean-up or other environmental claims, or the assertion of private litigation claims and/or damages that could be material.
On December 1, 2021, we completed the sale of GE's share of our boiler manufacturing business in China in our Power segment. In connection with the transaction, we recorded a loss on the disposal of this business of $170 million in Other income in our Statement of Earnings (Loss). See Note 18 for further information.

Purchases and sales of business interests (a)Included a pre-tax loss of $170 million on the sale of our boiler manufacturing business in China in 2021.
Revenues are classified according to the region to which equipment and services are sold. For purposes of this analysis, the U.S. is presented separately from the remainder of the Americas.

Year ended December 31, 2021AviationHealthcareRenewable EnergyPowerCorporateTotal
U.S.$9,675 $7,229 $7,275 $6,186 $2,473$32,838 
Non-U.S.
Europe3,920 3,702 3,651 3,621 5214,946 
China region2,419 2,700 464 1,145 166,744 
Asia (excluding China region)1,758 2,345 1,959 2,090 (45)8,107 
Americas1,310 923 1,009 1,239 (4)4,476 
Middle East and Africa2,228 826 1,340 2,622 697,085 
Total Non-U.S.$11,635 $10,496 $8,422 $10,717 $88$41,358 
Total geographic revenues$21,310 $17,725 $15,697 $16,903 $2,561$74,196 
Non-U.S. revenues as a % of total revenues55 %59 %54 %63 %56




Year ended December 31, 2020AviationHealthcareRenewable EnergyPowerCorporateTotal
U.S.$11,239 $7,611 $7,846 $6,186 $2,336$35,217 
Non-U.S.
Europe4,288 3,952 3,047 2,895 15914,342 
China region2,078 2,455 1,156 1,253 356,978 
Asia (excluding China region)1,842 2,264 1,484 2,707 (55)8,241 
Americas882 879 819 1,483 14,064 
Middle East and Africa1,713 848 1,314 3,064 526,991 
Total Non-U.S.$10,803 $10,398 $7,820 $11,403 $192$40,616 
Total geographic revenues$22,042 $18,009 $15,666 $17,589 $2,528$75,833 
Non-U.S. revenues as a % of total revenues49 %58 %50 %65 %54 %

Year ended December 31, 2019
U.S.$13,384 $8,526 $7,413 $5,992 $3,648$38,963 
Non-U.S.
Europe7,452 4,132 2,925 3,140 (131)17,519 
China region3,050 2,747 698 974 (27)7,442 
Asia (excluding China region)3,591 2,690 2,038 3,044 (102)11,260 
Americas1,593 1,056 1,064 1,915 (31)5,597 
Middle East and Africa3,805 792 1,198 3,560 869,441 
Total Non-U.S.$19,491 $11,416 $7,924 $12,633 $(206)$51,258 
Total geographic revenues$32,875 $19,942 $15,337 $18,625 $3,442$90,221 
Non-U.S. revenues as a % of total revenues59 %57 %52 %68 %57 %

REMAINING PERFORMANCE OBLIGATION. As of December 31, 2021, the aggregate amount of the contracted revenues allocated to our unsatisfied (or partially unsatisfied) performance obligations was $239,820 million. We expect to recognize revenue as we satisfy our remaining performance obligations as follows: 1) equipment-related remaining performance obligation of $45,065 million of which 53%, 77% and 98% is expected to be recognized within 12 and 5 years, respectively, and the remaining thereafter; and 2) services-related remaining performance obligations of $194,755 million of which 10%, 41%, 63% and 80% is expected to be recognized within 1510 and 15 years, respectively, and the remaining thereafter. Contract modifications could affect both the timing to complete as well as the amount to be received as we fulfill the related remaining performance obligations.



Comments